Cargando…

Treatment of Vitamin K Deficiency in Hemodialysis Patients – A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet

PURPOSE: Vitamin K deficiency and hence a high level of plasma dephosphorylated undercarboxylated matrix Gla protein (dp-ucMGP) is frequent in patients on hemodialysis. This group is recommended to restrict their potassium intake which often leads to restriction of vitamin K rich foods. A menaquinon...

Descripción completa

Detalles Bibliográficos
Autores principales: Lentz, Katrine Aagaard, Vahlgren, Julie, Hansen, Ditte, Plebani, Mario, Fusaro, Maria, Rasmussen, Lars Melholt, Jakobsen, Jette, Sloth, Jens Jørgen, Post Hansen, Henrik, Andersen, Jens Rikardt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586167/
https://www.ncbi.nlm.nih.gov/pubmed/36277743
http://dx.doi.org/10.2147/IJNRD.S365912
_version_ 1784813638437044224
author Lentz, Katrine Aagaard
Vahlgren, Julie
Hansen, Ditte
Plebani, Mario
Fusaro, Maria
Rasmussen, Lars Melholt
Jakobsen, Jette
Sloth, Jens Jørgen
Post Hansen, Henrik
Andersen, Jens Rikardt
author_facet Lentz, Katrine Aagaard
Vahlgren, Julie
Hansen, Ditte
Plebani, Mario
Fusaro, Maria
Rasmussen, Lars Melholt
Jakobsen, Jette
Sloth, Jens Jørgen
Post Hansen, Henrik
Andersen, Jens Rikardt
author_sort Lentz, Katrine Aagaard
collection PubMed
description PURPOSE: Vitamin K deficiency and hence a high level of plasma dephosphorylated undercarboxylated matrix Gla protein (dp-ucMGP) is frequent in patients on hemodialysis. This group is recommended to restrict their potassium intake which often leads to restriction of vitamin K rich foods. A menaquinone-7 (MK-7) supplement has been shown to decrease dp-ucMGP, but it has yet to be examined if a vitamin K rich diet could be equally effective. PATIENTS AND METHODS: A prospective randomized crossover intervention trial with two arms; 6 weeks of 360 μg MK-7 tablet/day and 6 weeks of a vitamin K rich diet with a 3-week washout period in between. Participants were 10 patients in hemodialysis and the primary outcome measures were changes in dp-ucMGP, total MGP (tMGP), and undercarboxylated osteocalcin (ucOC). Furthermore, the level of potassium and phylloquinone in broccoli was determined after different durations of boiling. RESULTS: During the MK-7 intervention the dp-ucMGP and ucOC decreased significantly compared to baseline (−0.42 [−0.93; −0.22] nmol/L (p=<0.01) and −1.85 [−2.91; −1.30] nmol/L (p<0.01)), while these were unchanged during the dietary intervention (0.03 [−0.64; 0.37] nmol/L (p=1.00) and 0.30 [−1.71; 1.41] nmol/L (p=0.77)). Between the two interventions there was a greater decrease in ucOC (p=0.02) during the MK-7 compared to the dietary period. No significant changes in the total MGP levels were found in any of the periods. The retention of potassium following boiling for 2 minutes and 8 minutes was 76% and 49%, respectively, while for phylloquinone the retention was 92%, and independent of duration of boiling. CONCLUSION: A daily MK-7 supplement for 6 weeks lowered dp-ucMGP and ucOC significantly, while a vitamin K rich diet was not able to induce any significant effect. Boiled broccoli maintains a reasonable content of phylloquinone while potassium is extracted and is a reasonable source of phylloquinone for patients on hemodialysis.
format Online
Article
Text
id pubmed-9586167
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-95861672022-10-22 Treatment of Vitamin K Deficiency in Hemodialysis Patients – A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet Lentz, Katrine Aagaard Vahlgren, Julie Hansen, Ditte Plebani, Mario Fusaro, Maria Rasmussen, Lars Melholt Jakobsen, Jette Sloth, Jens Jørgen Post Hansen, Henrik Andersen, Jens Rikardt Int J Nephrol Renovasc Dis Original Research PURPOSE: Vitamin K deficiency and hence a high level of plasma dephosphorylated undercarboxylated matrix Gla protein (dp-ucMGP) is frequent in patients on hemodialysis. This group is recommended to restrict their potassium intake which often leads to restriction of vitamin K rich foods. A menaquinone-7 (MK-7) supplement has been shown to decrease dp-ucMGP, but it has yet to be examined if a vitamin K rich diet could be equally effective. PATIENTS AND METHODS: A prospective randomized crossover intervention trial with two arms; 6 weeks of 360 μg MK-7 tablet/day and 6 weeks of a vitamin K rich diet with a 3-week washout period in between. Participants were 10 patients in hemodialysis and the primary outcome measures were changes in dp-ucMGP, total MGP (tMGP), and undercarboxylated osteocalcin (ucOC). Furthermore, the level of potassium and phylloquinone in broccoli was determined after different durations of boiling. RESULTS: During the MK-7 intervention the dp-ucMGP and ucOC decreased significantly compared to baseline (−0.42 [−0.93; −0.22] nmol/L (p=<0.01) and −1.85 [−2.91; −1.30] nmol/L (p<0.01)), while these were unchanged during the dietary intervention (0.03 [−0.64; 0.37] nmol/L (p=1.00) and 0.30 [−1.71; 1.41] nmol/L (p=0.77)). Between the two interventions there was a greater decrease in ucOC (p=0.02) during the MK-7 compared to the dietary period. No significant changes in the total MGP levels were found in any of the periods. The retention of potassium following boiling for 2 minutes and 8 minutes was 76% and 49%, respectively, while for phylloquinone the retention was 92%, and independent of duration of boiling. CONCLUSION: A daily MK-7 supplement for 6 weeks lowered dp-ucMGP and ucOC significantly, while a vitamin K rich diet was not able to induce any significant effect. Boiled broccoli maintains a reasonable content of phylloquinone while potassium is extracted and is a reasonable source of phylloquinone for patients on hemodialysis. Dove 2022-10-17 /pmc/articles/PMC9586167/ /pubmed/36277743 http://dx.doi.org/10.2147/IJNRD.S365912 Text en © 2022 Lentz et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lentz, Katrine Aagaard
Vahlgren, Julie
Hansen, Ditte
Plebani, Mario
Fusaro, Maria
Rasmussen, Lars Melholt
Jakobsen, Jette
Sloth, Jens Jørgen
Post Hansen, Henrik
Andersen, Jens Rikardt
Treatment of Vitamin K Deficiency in Hemodialysis Patients – A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet
title Treatment of Vitamin K Deficiency in Hemodialysis Patients – A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet
title_full Treatment of Vitamin K Deficiency in Hemodialysis Patients – A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet
title_fullStr Treatment of Vitamin K Deficiency in Hemodialysis Patients – A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet
title_full_unstemmed Treatment of Vitamin K Deficiency in Hemodialysis Patients – A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet
title_short Treatment of Vitamin K Deficiency in Hemodialysis Patients – A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet
title_sort treatment of vitamin k deficiency in hemodialysis patients – a pilot study comparing menaquinone-7 tablets and a vitamin k rich diet
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586167/
https://www.ncbi.nlm.nih.gov/pubmed/36277743
http://dx.doi.org/10.2147/IJNRD.S365912
work_keys_str_mv AT lentzkatrineaagaard treatmentofvitaminkdeficiencyinhemodialysispatientsapilotstudycomparingmenaquinone7tabletsandavitaminkrichdiet
AT vahlgrenjulie treatmentofvitaminkdeficiencyinhemodialysispatientsapilotstudycomparingmenaquinone7tabletsandavitaminkrichdiet
AT hansenditte treatmentofvitaminkdeficiencyinhemodialysispatientsapilotstudycomparingmenaquinone7tabletsandavitaminkrichdiet
AT plebanimario treatmentofvitaminkdeficiencyinhemodialysispatientsapilotstudycomparingmenaquinone7tabletsandavitaminkrichdiet
AT fusaromaria treatmentofvitaminkdeficiencyinhemodialysispatientsapilotstudycomparingmenaquinone7tabletsandavitaminkrichdiet
AT rasmussenlarsmelholt treatmentofvitaminkdeficiencyinhemodialysispatientsapilotstudycomparingmenaquinone7tabletsandavitaminkrichdiet
AT jakobsenjette treatmentofvitaminkdeficiencyinhemodialysispatientsapilotstudycomparingmenaquinone7tabletsandavitaminkrichdiet
AT slothjensjørgen treatmentofvitaminkdeficiencyinhemodialysispatientsapilotstudycomparingmenaquinone7tabletsandavitaminkrichdiet
AT posthansenhenrik treatmentofvitaminkdeficiencyinhemodialysispatientsapilotstudycomparingmenaquinone7tabletsandavitaminkrichdiet
AT andersenjensrikardt treatmentofvitaminkdeficiencyinhemodialysispatientsapilotstudycomparingmenaquinone7tabletsandavitaminkrichdiet